The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 1-15A B Cell Lymphoma: Molecular Mechanism/Therapeutic Target

Fri. Oct 11, 2019 9:00 AM - 10:00 AM No.15 (Tokyo International Forum, 7F G701)

Chair: Koichi Sugimoto (Dept of Hematol/Oncol, JR Tokyo General Hospital, Tokyo, Japan)

[OS1-15A-6] Elotuzumab enhances anti-tumor activity of Vγ9Vδ2T cells against primary effusion lymphoma

Kosuke Maeda, Ryusho Kariya, Jutatip Panaampon, Gunya Sittithumcharee, Seiji Okada (Hematopoiesis, Research Center for Human Retrovirus, Kumamoto Univ., Kumamoto, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password